Pharmaceuticals Market Research Reports

Pharmaceutical Market

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this industry. The pharmaceutical market, valued as a multi-billion dollar market, is undoubtedly the largest revenue generator for the life sciences industry.

The pharmaceutical industry can be divided into numerous market segments based on the different therapeutic areas and applications. The largest segment, the market for cardiovascular drugs, records huge sales every year. The rising world population, rapid ageing of the same, and an increased prevalence of diseases are the major factors driving growth of this industry. The recent breakthroughs in proteomics and genomics have led to the development of modernized approaches to drug discovery and development in the industry, for the possibility of newer, advanced, and more sophisticated therapies and drugs. Developments in biotechnology research have led to introduction of advanced therapies involving biopharmaceuticals, regenerative medicine, stem cells, etc. These new age therapies and products have caused ease of treatment procedures and enabled speedy recovery from various disorders. Technological growth in such interdisciplinary fields has opened up new arenas in drug discovery, drug delivery, and life sciences research.
Certain incurable diseases like cancer and AIDS, which are therapeutic areas of prime concern for scientists and doctors all over the world, depict immense growth potential for the pharmaceutical industry in the future. Surfacing of newer diseases and therefore, the rising requirement of newer drug delivery methods, explains the greater than before importance of research and development activities in the industry. Industry leaders now generously allocate around 20% of their turnover to R&D to allot the finest instruments and manpower for their use. This has helped them maintain a competitive edge over other players in the market. However, the high costs of R&D, shorter product life cycles, and trouble producing a ‘best-seller’ has introduced the trend of mergers, acquisitions, strategic alliances, and most importantly, outsourcing in the industry. Numerous companies have been entering into global tie-ups and collaborations pooling and utilizing their resources for R&D and new product development in almost all areas. With this ongoing and rapidly developing trend, countries have shown great interest in encouraging investments in developing R&D and manufacturing facilities by public funding and tax exemptions.

The industry, however, faces certain major challenges, one of them being the imbalance between the rate of introduction of novel drugs and that of patent expiry of the already existing brands. Rising research investments, development of better infrastructure, efficient allocation of resources, etc. are some of the measures adopted by players to cope with this problem. Stringent governmental regulation of this market in certain countries also sometimes restricts growth and causes loss of potential opportunities. However, certain regulatory measures such as patent protection for novel and blockbuster drugs helps manufacturers recover the massive investment costs incurred during the discovery, development, and commercialization of products. On the other hand, there are generic versions of drugs which are available at minimal prices as compared to patented drugs. These address the issue of affordability of drugs to the lower income groups.
Presently, the global pharmaceutical market is dominated by the United States. But huge double-digit growth rates are being observed in developing countries too, China and India being the best examples. This is mainly due to a large number of established multinational pharmaceutical companies outsourcing their research and manufacturing activities to these countries, owing to the favorable cost factor, modernized infrastructure, and a large and skilled base of scientifically knowledgeable manpower. Also, other emerging regional markets like Brazil, Russia, Germany, France, Spain, etc., continue to show tremendous growth in the pharmaceutical sector.

This section on pharmaceutical industry research consists of market research reports on its various segments like Cardiovascular drugs, Anesthesia drugs, Drug Discovery and Development, Dentistry, Dermatology, Blood and blood products, Clinical Diagnostics,  In vitro/Molecular Diagnostics, Radiology, Oncology, Dietary Supplements, Vaccines, Generics, and OTC drugs. The reports presented in this section include in-depth industry analysis involving major market players, latest market trends, new product developments, growth drivers, growth restrainers, market forecasts, and so on.

View More
TITLE Actions
Global Neutropenia Treatment Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against ...

Global Myelodysplastic Syndrome Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Myelodysplastic syndromes (MDS) are a group of cancers in which immature blood cells in the bone marrow do not mature and therefore do not become healthy blood cells.[2] Early on there are typically no symptoms.Later symptoms may includ...

Global Myasthenia Gravis Drugs Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenan...

Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Musculoskeletal disorders are the group of pain disorders or injuries that affect the body's joints, muscles, nerves, ligaments, tendons, and structures, all of which support the hands, legs, neck and back. The pain and discomfort vary ...

Global Muscle Relaxant Drugs Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral pa...

Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neuron...

Global MRSA Drugs Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called met...

Global Mouth Ulcer Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Mouth ulcers are common and should clear up on their own within a week or two. They're rarely a sign of anything serious but may be uncomfortable to live with. The morden life, people work for extra hours to meet the deliverables...

Global Gastrointestinal OTC Drugs Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, ...

Global Foot and Mouth Disease Vaccines Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock a...

Global Fibromyalgia Drugs Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure. The APAC is a major untapped market with many leading vendors in the global fibromyalgia drugs market....

Global Fibrin Sealants Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Fibrin sealant, a two-component substance consisting of thrombin and fibrinogen, is used as a hemostatic or adhesive in various surgical solutions. In clinical practice, a fibrin sealant consists of a concentrated solution of fibrinogen...

Global Female Contraceptive Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology. Female contraceptive devices account for major shares of the contraceptive pills market t...

Global Female Condoms Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

A female condom is a birth control device that acts as a barrier to prevent sexual fluids from entering the vagina during intercourse. It protects against pregnancy and sexually transmitted infections (STIs). The online stores wi...

Global Fatty Acid Supplements Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Fatty acid supplements are types of dietary supplements taken to meet the required level of omega-3 and omega-6 fatty acids in the body. These supplements are available in various formulations such as capsules, soft gels, and tablets an...

Global Factor VIII Deficiency Treatment Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. ...

Global Factor IX Deficiency Treatment Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophy...

Global Facial Injectables Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Injectables are a combination of dermal fillers and Botox used in facial aesthetic treatments, which help reduce wrinkles and play a crucial role in rejuvenating facial skin for smoother and younger look. These are injected under the sk...

Global Excipients Market Insights, Forecast to 2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Excipients are inert substances that are generally used to manufacture different forms of drugs and are present in the finished products. Excipients help in providing long-term stability and make solid formulations bulkier. They also im...

Global Epilepsy Therapeutic Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregn...

We are on:

Need Help?